NCT02175186View on ClinicalTrials.gov

Effect of ALBIS on Gastroduodenal Mucosal Injury in Patients Receiving Dual Antiplatelet Therapy After Percutaneous Coronary Intervention

PHASE4CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

January 21, 2015

Primary Completion Date

December 1, 2018

Study Completion Date

January 8, 2019

Conditions
GastritisGastroduodenal Ulcer
Interventions
DRUG

ALBIS

DRUG

Placebo

Trial Locations (1)

Unknown

Asan Medical Center, Seoul

All Listed Sponsors
lead

Young-Hak Kim, MD, PhD

OTHER

NCT02175186 - Effect of ALBIS on Gastroduodenal Mucosal Injury in Patients Receiving Dual Antiplatelet Therapy After Percutaneous Coronary Intervention | Biotech Hunter | Biotech Hunter